Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 8/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | BLM | P54132 | 2/20 | 0.62 |
| ▸ | NPC1 | O15118 | 2/20 | 0.62 |
| ▸ | USP2 | O75604 | 2/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | ALPG | P10696 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | XBP1 | P17861 | 1/20 | 0.62 |
| ▸ | CRHBP | P24387 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12020959 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL29551581 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL29819404 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL12932092 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL16211709 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL29696603 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL29539035 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL17694077 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL903226 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 | |
| SCHEMBL13994353 | 1.00 | PRMT1 (0.73) | PRMT1MAPTBLMNPC1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605336-B2 | Fusogenic liposome-coated porous silicon nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-21 | — | — | US | disclosed |
| US-20250064740-A1 | MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO | KARMA BIOTECHNOLOGIES (US) | 2025-02-27 | — | — | US | disclosed |
| EP-3316850-B1 | FUSOGENIC LIPOSOME-COATED POROUS SILICON NANOPARTICLES | UNIV CALIFORNIA (US) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023137227-A9 | MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO | KARMA BIOTECHNOLOGIES (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2023137227-A1 | MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO | KARMA BIOTECHNOLOGIES (US) | 2023-07-20 | — | — | WO | disclosed |
| US-20230108831-A1 | Scaffold-Free Nerve Conduit | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2023-04-06 | — | — | US | disclosed |
| US-20230095861-A1 | FUSOGENIC LIPOSOME-COATED POROUS SILICON NANOPARTICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-03-30 | — | — | US | disclosed |
| US-20220257801-A1 | PARTICULATE STRUCTURES MADE FROM GOLD NANOPARTICLES, METHODS FOR PREPARING SAME AND USES THEREOF FOR TREATING SOLID TUMOURS | UNIVERSITE DE FRANCHE COMTE (FR) | 2022-08-18 | — | — | US | disclosed |
| US-11406597-B2 | Fusogenic liposome-coated porous silicon nanoparticles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-08-09 | — | — | US | disclosed |
| EP-4003431-A1 | PARTICULATE STRUCTURES MADE FROM GOLD NANOPARTICLES, METHODS FOR PREPARING SAME AND USES THEREOF FOR TREATING SOLID TUMOURS | Universite De Franche Comte (FR) | 2022-06-01 | — | — | EP | disclosed |
| EP-3524686-A1 | METHOD FOR DETECTING ANTIBIOTIC-RESISTANT CELLS USING GENETIC ENGINEERED TRANSDUCTION PARTICLES | Geneweave Biosciences Inc. (US) | 2019-08-14 | — | — | EP | disclosed |
| EP-3134722-B1 | REAGENT CARTRIDGE | GENEWEAVE BIOSCIENCES INC (US) | 2019-02-20 | — | — | EP | disclosed |
| US-10125386-B2 | Reagent cartridge and methods for detection of cells | GeneWeave Biosciences, Inc. (US) | 2018-11-13 | — | — | US | disclosed |
| US-20180193268-A1 | FUSOGENIC LIPOSOME-COATED POROUS SILICON NANOPARTICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-07-12 | — | — | US | disclosed |
| US-20180153984-A1 | ADJUVANT PARTICLES COMPRISING ADENOSINE RECEPTOR ANTAGONISTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-06-07 | — | — | US | disclosed |
| US-20170233783-A1 | REAGENT CARTRIDGE AND METHODS FOR DETECTION OF CELLS | GeneWeave Biosciences, Inc. (US) | 2017-08-17 | — | — | US | disclosed |
| US-9540675-B2 | Reagent cartridge and methods for detection of cells | GeneWeave Biosciences, Inc. (US) | 2017-01-10 | — | — | US | disclosed |
| US-20150218613-A1 | REAGENT CARTRIDGE AND METHODS FOR DETECTION OF CELLS | GeneWeave Biosciences, Inc. (US) | 2015-08-06 | — | — | US | disclosed |
| WO-2014176934-A1 | USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING ANGIOGENESIS RELATED DISEASES | 河北以岭医药研究院有限公司 (CN) | 2014-11-06 | — | — | WO | disclosed |
| CN-104127798-A | Application of traditional Chinese medicine composition in preparation of medicine used for inhibiting metastasis of cancer cells to peritoneum | HEBEI YILING MEDICINE RES INST CO LTD | 2014-11-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230095861-A1 | FUSOGENIC LIPOSOME-COATED POROUS SILICON NANOPARTICLES | FUS, NSF, SELPLG | PRMT1 3694/4885MAPT 2442/4885BLM 3517/4885 |
| US-12605336-B2 | Fusogenic liposome-coated porous silicon nanoparticles | NSF, FUS, STIM1 | PRMT1 3856/4885MAPT 1246/4885BLM 4407/4885 |
| US-11406597-B2 | Fusogenic liposome-coated porous silicon nanoparticles | FUS, NSF, SELPLG | PRMT1 3694/4885MAPT 2442/4885BLM 3517/4885 |
| US-20220257801-A1 | PARTICULATE STRUCTURES MADE FROM GOLD NANOPARTICLES, METHODS FOR PREPARING SAME AND USES THEREOF FOR TREATING SOLID TUMOURS | ARG1, ADCYAP1R1, ASGR1 | PRMT1 221/4885MAPT 588/4885BLM 1243/4885 |
| US-20180193268-A1 | FUSOGENIC LIPOSOME-COATED POROUS SILICON NANOPARTICLES | FUS, NSF, SELPLG | PRMT1 3694/4885MAPT 2442/4885BLM 3517/4885 |
| US-20250064740-A1 | MULTI-VESICULAR LIPID NANOPARTICLE TOLEROGENIC VACCINES FOR INDUCTION OF SYSTEMIC IMMUNE TOLERANCE IN VIVO | PLTP, CD47, PHOSPHO1 | PRMT1 4117/4885MAPT 2489/4885BLM 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.